EP1554191B1 - Rigid plastic protective case for a blister pack - Google Patents

Rigid plastic protective case for a blister pack Download PDF

Info

Publication number
EP1554191B1
EP1554191B1 EP03773732A EP03773732A EP1554191B1 EP 1554191 B1 EP1554191 B1 EP 1554191B1 EP 03773732 A EP03773732 A EP 03773732A EP 03773732 A EP03773732 A EP 03773732A EP 1554191 B1 EP1554191 B1 EP 1554191B1
Authority
EP
European Patent Office
Prior art keywords
case
blister
upper panel
blister pack
hinge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP03773732A
Other languages
German (de)
French (fr)
Other versions
EP1554191A1 (en
Inventor
Hervé GATTEFOSSE
Patrick Sivera
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Publication of EP1554191A1 publication Critical patent/EP1554191A1/en
Application granted granted Critical
Publication of EP1554191B1 publication Critical patent/EP1554191B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/04Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills
    • B65D83/0445Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments
    • B65D83/0463Containers or packages with special means for dispensing contents for dispensing annular, disc-shaped, or spherical or like small articles, e.g. tablets or pills all the articles being stored in individual compartments formed in a band or a blisterweb, inserted in a dispensing device or container
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/03Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
    • A61J1/035Blister-type containers

Definitions

  • the invention relates to a protective case for a blister containing medicaments.
  • the invention more particularly relates to a protective case for a blister, containing medicaments for clinical trials, of the type comprising a semi-rigid horizontal upper plate comprising blister-shaped cells delimiting open housing downwards which are sealed with lids and each containing a medicament capable of being expelled by the flat underside of the blister by tearing the blister operculum.
  • a drug is clinically tested before being marketed.
  • the effectiveness of the drug is tested by administering the active ingredient to a first group of patients and by administering a placebo to a second control group of patients.
  • the case consists of a folded flexible cardboard sheet comprising a central panel flanked by two lateral flaps that can be folded down on the central flap.
  • the blister is trapped between the central panel and a first lateral flap.
  • the central panel and the first flap are each perforated with holes matching the location of the cells.
  • the perforated flap is then folded down and then sealed on the central panel, for example by gluing.
  • the holes of the central panel allow the ejection of the drug by pressing on the cell and tearing of the lid, the drug then being recovered under the underside of the case.
  • the second lateral flap forms a cover for protecting the cells of the blister.
  • the drug information leaflet is located on one or both sides of the lid.
  • packaging the blister in such a case requires a first operation of positioning the blister in the pre-glued case, then a gluing operation of the perforated flap on the central flap which can take up to 7 seconds.
  • US-A-3,587,517 describes for example a case which has a rigid bottom on which a rigid flap is rotatably mounted around a lateral hinge.
  • a drug blister is intended to be clamped flat between the bottom and the flap.
  • the bottom and the flap have holes matching the location of the cells of the blister.
  • the case also has a rigid cover which is rotatably mounted relative to the bottom between a folded position above the flap so as to protect the cells from shocks, and an open position in which the cells are accessible.
  • US-A-4998623, US-A-5323907, US-A-6082544 and US-A3587517 are considered to represent the state of the art.
  • this case is not suitable for use in clinical trials.
  • the case is reusable because the flap has reversible closure means relative to the bottom. It is thus possible to replace the original blister a similar blister but containing substances of different nature without the appearance of the holster suggests such a substitution.
  • it is essential that the case is tamperproof once the blister is trapped between the bottom and the flap.
  • the invention proposes a case of the type described above, characterized in that the fastening means are fastening means that can not be dismounted by elastic interlocking.
  • a longitudinal, vertical and transverse orientation indicated by the trihedron L, V, T of FIG. 1 will be used in the remainder of the description and in the claims, in a non-limiting manner.
  • FIG. 1 a protective case 10 of a blister 12 of drugs.
  • the case 10 is here empty and is in an unfolded state of origin in which it is ready to receive the drug blister 12.
  • the blister 12 comprises a semi-rigid horizontal top plate 14 which comprises cells 16, in the form of blisters defining open housing downwards which are closed by lids 17 shown in Figure 7.
  • Each housing can to shelter a drug 19 that can be expelled by the flat lower face 18 of the blister 12 by deformation of the cell 16 and by tearing of the lid 17 as illustrated by the central cell 16 in FIG. 7.
  • the drugs 19 are packaged for example in the form of tablets, capsules, suppositories likely to be protected by a blister.
  • the case 10 comprises in particular a central bottom 20 which is mainly formed by a horizontal plate generally rectangular whose small front sides 22 and rear 24 are oriented transversely and whose long lateral sides 26 and 28 are oriented longitudinally according to Figure 1.
  • the bottom 20 is in particular intended to support the flat lower face 18 of the blister 12 which is placed along the arrow F of FIG.
  • the bottom plate 20 has a side edge 30 which extends vertically upwardly from the two long sides 26 and 28 as well as from the rear small side 24.
  • a rectangular and flat flap 32 is mounted articulated around a transverse hinge front 34, on the small front side 22 of the bottom 20, between an unfolded position and a folded position.
  • the flap 32 In the folded position, as shown in FIGS. 2 and 7, the flap 32 generally covers the bottom 20 in order to trap the blister 12 between the lower face 36 of the flap 32 and the upper face 38 of the bottom 20. The flap 32 is then surrounded by the edge 30 of the bottom 20.
  • the flap 32 and the bottom 20 respectively comprise holes 40 and 42 which are made in concordance with the locations of the cells 16 of the blister 12 when the flap 32 is in the folded position.
  • the cells 16 and the holes 40 and 42 are here made in the form of four longitudinal rows of nine units.
  • the holes 40 of the flap 32 give access to the cells 16 to the user who can thus select a drug 19 and eject it by pressing vertically on the cell 16 chosen, the drug 19 being then ejected to through the cover 17 and the associated hole 42 of the bottom 20 as illustrated by the arrow F 'of FIG. 7.
  • the case 10 comprises non-removable or tamper-proof means for fastening the flap 32 in the folded position on the bottom 20.
  • the flap 32 is more precisely fixed by vertical elastic engagement of a series of pairs of elements each comprising a male element 44 and a female element 46.
  • the fastening means are shown in more detail in FIGS. 4 and 5.
  • the male element 44 consists of a lug 48 which extends vertically upwards from the upper face 38 of the bottom 20.
  • the free end of the lug 48 has a head 50 in the form of a half-sphere whose horizontal flat is oriented downwards.
  • the lug 48 is intended to cooperate with the associated female element 46 which is carried by the flap 32.
  • the female element 46 is a well 54 with a pierced bottom which extends vertically from the surface upper portion 56 of the flap 32.
  • the well 54 has a lower opening 52 intended to receive the hemispherical head 50 of the lug 48.
  • the well 54 also has vertical slots which divide the well 54 into two symmetrical halves in order to facilitate its elastic deformation and consequently the engagement of the male element 44.
  • the well 54 has a frustoconical shape whose lower base is located at the opening 52 and which is intended to increase the resistance to disengagement by clamping effect.
  • the engagement apertures 52 of the shutter 32 are encircled by a skirt 58 for protecting the pairs of fixing elements 44, 46 which extends vertically from the upper surface 56 of the shutter 32 and that prevents any attempt to disassemble by spacing the two halves of each well 54.
  • the pairs of elements 44, 46 for fixing elastic interlocking are here six in number.
  • the lugs 48 carried by the bottom 20 are distributed on the periphery of the bottom 20 at the rate of two lateral lugs 48L on each large lateral side 26 and 28 of the bottom 20 and two front lugs 48F on the small rear side 24.
  • the lugs 48 determine precisely the horizontal position of the blister 12 with respect to the ejection holes 42 during the introduction of the latter in the bottom 20 and before folding the flap 32.
  • the small front side 22 of the blister 12 is adjacent to the hinge before 34.
  • the lugs 48 and the front hinge 34 thus advantageously form positioning stops for the blister 12 relative to the bottom 20.
  • the case 10 also comprises a cover 60 which is particularly visible in FIGS. 2 and 6.
  • the cover 60 is a plate of dimensions roughly similar to those of the bottom 20.
  • the cover 60 is hingedly mounted on the upper edge of the edge 30 of the small rear side 24, around a rear transverse hinge 62, between an open position and a closed position.
  • the lid 60 discovers the upper portion of the blister 12 so as to allow access to the drugs 19 to a user.
  • the lid can be opened at 180 ° while completely freeing access to the blister.
  • the cover 60 In the closed position, as shown in FIG. 6, the cover 60 is generally horizontal and its lower cuff 64 is pressed on the upper edge of the edge 30 of the bottom 20.
  • the cover 60 has at its free end, that is to say say the opposite side to the rear hinge 62, a flange 66 which extends perpendicularly from its cuff 64 so as to close the small front side 22 of the case 10 which has no vertical edge 30.
  • the cover 60 encloses and protects the upper face 14 of the blister 12, and in particular the cells 16. In the closed position, only the obverse 68 of the cover 60 is visible.
  • the obverse 68 of the cover 60 may in particular serve as a support for an information notice 70 on the drugs 19 contained in the case 10.
  • the notice 70 is for example glued on the obverse 68 or on the reverse side 64.
  • the record can also be printed or inscribed on the cover in recess or in relief.
  • the flap 32 has two tabs 72 which protrude beyond the front hinge 34. In the folded position of the flap 32, these two tabs 72 extend horizontally from the small front side 22 of the case 10.
  • the tabs 72 are intended to hook the lid 60 in the closed position by elastic interlocking with grooves (not shown) carried by the flange 66 of the lid 60.
  • the middle of the flange 66 of the cover 60 draws a boss 74 forming a grip to allow the user to disengage the cover 60 from the grip of the tabs 72 to open the case 10 by lifting.
  • the case 10 is here made entirely of rigid plastic material.
  • the case 10 is thus resistant to shocks, and its mechanical properties are not altered when exposed to a humid atmosphere.
  • the case 10 is made integrally by molding in one piece.
  • the front hinges 34 and rear 62 are then each made of a plastic film integrally formed with the bottom 20.
  • the case 10 is advantageously made of a polypropylene-type material so that the closures and repeated openings of the lid 60 do not cause fatigue failure of the rear hinge 62 during use of the case 10.
  • the lugs 48 are also made integral with the bottom 20, and the female elements are made integrally with the flap 32. The manufacture of this case 10 does not require any assembly operation since it consists of a single piece.
  • the flap 32 is folded over the blister 12 against the bottom 20.
  • the blister 12 is then automatically positioned horizontally because the fold formed at the front hinge 34 by the flap 32 and the bottom 20 pushes the blister 12 which is laterally guided in position by the lateral lugs 48L, and stopped in abutment against the front lugs 48F.
  • the wells 54 of the flap 32 are then brought vertically in contact with the lugs 48 which penetrate through the lower opening 52.
  • the rounded head 50 of the lug 48 elastically separates the two halves of the well 54.
  • the well 54 is recalled elastically in its original form against the lug 48, under the head 50.
  • the pairs of fasteners 44 and 46 are then in the nested position and the flap 32 thus traps the blister 12 against the bottom 20 in a way that can not be dismantled.
  • the user grasps the case 10 closed by supporting the underside of the bottom 20 in the palm of his hand and squeezing the two large lateral sides 26 and 28 between his fingers. Then he opens with the other hand the cover 60 of the case 10 by lifting the boss 74. Finally, he presses the finger the cell 16 containing the desired drug 19 to eject it through the hole 42 of the bottom 20, in the palm of the hand that supports the case 10.
  • the flap 32 being surrounded very closely by the edge 30 of the bottom 20, it is difficult to support to insert a lever in the gap between the flap 32 and the bottom 20 to lift the flap 32.
  • the only solution to reach the blister 12 is to cut the heads 50 of each lug 48, leaving indelible traces. That is to say that in case of rape, the case 10 carries traces impossible to camouflage.
  • the flap 32 and the bottom 20 are two separate parts.

Landscapes

  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Packages (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Description

L'invention concerne un étui de protection d'un blister contenant des médicaments.The invention relates to a protective case for a blister containing medicaments.

L'invention concerne plus particulièrement un étui de protection d'un blister, contenant des médicaments destinés à des essais cliniques, du type comportant une plaque supérieure horizontale semi-rigide comprenant des alvéoles en forme de cloques délimitant des logements ouverts vers le bas qui sont obturés par des opercules et qui contiennent chacun un médicament susceptible d'être expulsé par la face inférieure plate du blister par déchirure de l'opercule du blister.The invention more particularly relates to a protective case for a blister, containing medicaments for clinical trials, of the type comprising a semi-rigid horizontal upper plate comprising blister-shaped cells delimiting open housing downwards which are sealed with lids and each containing a medicament capable of being expelled by the flat underside of the blister by tearing the blister operculum.

L'étui est du type qui comporte :

  • un fond horizontal perforé sur lequel repose la face inférieure du blister ; et
  • une plaque supérieure perforée qui recouvre la face supérieure du blister ;
et du type dans lequel le blister est emprisonné entre le fond et la plaque supérieure qui comportent chacun des trous en concordance avec l'emplacement des alvéoles, l'étui comportant des moyens de fixation de la plaque supérieure par rapport au fond, le fond et la plaque supérieure de l'étui étant réalisés en matière plastique rigide.The case is of the type which comprises:
  • a perforated horizontal bottom on which rests the lower face of the blister; and
  • a perforated upper plate which covers the upper face of the blister;
and of the type in which the blister is trapped between the bottom and the top plate which each have holes in accordance with the location of the cells, the case comprising means for fixing the upper plate relative to the bottom, the bottom and the upper plate of the case being made of rigid plastic material.

Un médicament fait l'objet de tests cliniques avant d'être commercialisé. On teste par exemple l'efficacité du médicament en administrant le principe actif à un premier groupe de malades et en administrant un placebo à un second groupe témoin de malades.A drug is clinically tested before being marketed. For example, the effectiveness of the drug is tested by administering the active ingredient to a first group of patients and by administering a placebo to a second control group of patients.

Il est connu de livrer le médicament sous blister dans un étui en forme de portefeuille, aussi appelé « wallet », auquel est intégré une notice d'information concernant le médicament qu'il contient. Le blister est emprisonné dans l'étui, ou « wallet » de façon que le médicament soit toujours accompagné de la notice correspondante.It is known to deliver the blistered medicine in a wallet-shaped case, also called "wallet", which is integrated an information leaflet concerning the drug it contains. The blister is trapped in the case, or "wallet" so that the drug is always accompanied by the corresponding record.

Dans le cadre d'études cliniques dites en double-aveugle, les étuis doivent être indiscernables entre eux quel que soit leur contenu : placebo ou principes actifs.In double-blind clinical studies, the cases must be indistinguishable from each other regardless of their content: placebo or active ingredients.

Selon un exemple connu, l'étui est constitué d'une feuille de carton souple pliée comportant un panneau central flanqué de deux volets latéraux susceptibles d'être rabattus sur le volet central.According to a known example, the case consists of a folded flexible cardboard sheet comprising a central panel flanked by two lateral flaps that can be folded down on the central flap.

Le blister est emprisonné entre le panneau central et un premier volet latéral. Le panneau central et le premier volet sont chacun perforés de trous concordant avec l'emplacement des alvéoles. Le volet perforé est ensuite rabattu, puis scellé sur le panneau central, par exemple par collage. Les trous du panneau central permettent l'éjection du médicament par pression sur l'alvéole et déchirure de l'opercule, le médicament étant alors récupéré sous la face inférieure de l'étui.The blister is trapped between the central panel and a first lateral flap. The central panel and the first flap are each perforated with holes matching the location of the cells. The perforated flap is then folded down and then sealed on the central panel, for example by gluing. The holes of the central panel allow the ejection of the drug by pressing on the cell and tearing of the lid, the drug then being recovered under the underside of the case.

Le second volet latéral forme un couvercle de protection des alvéoles du blister. La notice d'information correspondant aux médicaments est située sur l'une ou les deux faces du couvercle.The second lateral flap forms a cover for protecting the cells of the blister. The drug information leaflet is located on one or both sides of the lid.

Un tel étui permet notamment d'utiliser le contenu du blister sans jamais le séparer de la notice. La permutation de médicaments ou d'un placebo est ainsi empêchée.Such a case allows in particular to use the contents of the blister without ever separating it from the record. The permutation of drugs or a placebo is thus prevented.

De plus, une tentative de viol de l'étui se traduit généralement par une dégradation visible.In addition, an attempt to violate the case usually results in visible degradation.

Cependant, un tel étui en carton est souple et il se déforme à l'usage. Le carton est en plus susceptible de se déformer s'il est exposé à une atmosphère humide.However, such a cardboard case is flexible and it deforms with use. The cardboard is more likely to deform if exposed to a humid atmosphere.

De plus, il est envisageable que lors d'un viol de l'étui, les dégradations soient camouflées en collant à nouveau le volet latéral perforé sur le panneau central.In addition, it is conceivable that during a rape of the holster, the degradations are camouflaged by gluing again the perforated side flap on the central panel.

Enfin, le conditionnement du blister dans un tel étui nécessite une première opération de positionnement du blister dans l'étui préencollé, puis une opération de collage du volet perforé sur le volet central qui peut prendre jusqu'à 7 secondes.Finally, packaging the blister in such a case requires a first operation of positioning the blister in the pre-glued case, then a gluing operation of the perforated flap on the central flap which can take up to 7 seconds.

Le document US-A-3.587.517 décrit par exemple un étui qui comporte un fond rigide sur lequel un volet rigide est monté à rotation autour d'une charnière latérale. Un blister de médicament est destiné à être enserré à plat entre le fond et le volet. Le fond et le volet comportent des trous concordant avec l'emplacement des alvéoles du blister. L'étui comporte aussi un couvercle rigide qui est monté à rotation par rapport au fond entre une position rabattue au-dessus du volet de manière à protéger les alvéoles des chocs, et une position ouverte dans laquelle les alvéoles sont accessibles. Les documents US-A-4998623, US-A-5323907, US-A-6082544 et US-A3587517 sont considerés comme répresentant l'état de la technique.US-A-3,587,517 describes for example a case which has a rigid bottom on which a rigid flap is rotatably mounted around a lateral hinge. A drug blister is intended to be clamped flat between the bottom and the flap. The bottom and the flap have holes matching the location of the cells of the blister. The case also has a rigid cover which is rotatably mounted relative to the bottom between a folded position above the flap so as to protect the cells from shocks, and an open position in which the cells are accessible. US-A-4998623, US-A-5323907, US-A-6082544 and US-A3587517 are considered to represent the state of the art.

Cependant, cet étui n'est pas adapté à un usage dans le cadre d'essais cliniques. L'étui est en effet réutilisable, car le volet comporte des moyens de fermeture réversible par rapport au fond. Il est ainsi possible de substituer au blister d'origine un blister similaire mais contenant des substances de nature différente sans que l'apparence de l'étui ne laisse supposer une telle substitution. Pour que le résultat des essais cliniques soit fiable, il est donc indispensable que l'étui soit inviolable une fois que le blister est emprisonné entre le fond et le volet.However, this case is not suitable for use in clinical trials. The case is reusable because the flap has reversible closure means relative to the bottom. It is thus possible to replace the original blister a similar blister but containing substances of different nature without the appearance of the holster suggests such a substitution. For the result of clinical trials is reliable, it is essential that the case is tamperproof once the blister is trapped between the bottom and the flap.

Afin d'améliorer les temps de conditionnement et de résoudre les autres problèmes cités ci-dessus, l'invention propose un étui du type décrit précédemment, caractérisé en ce que les moyens de fixation sont des moyens de fixations indémontables par emboîtement élastique.In order to improve the conditioning times and to solve the other problems mentioned above, the invention proposes a case of the type described above, characterized in that the fastening means are fastening means that can not be dismounted by elastic interlocking.

Selon d'autres caractéristiques de l'invention :

  • l'étui comporte au moins un ergot formant butée de positionnement horizontal du blister par rapport aux trous d'éjection du fond de l'étui ;
  • l'ergot constitue un élément mâle des moyens de fixation par emboîtement élastique, l'élément femelle associé étant porté par la plaque supérieure ;
  • l'élément mâle et l'élément femelle sont réalisés venus de matière avec le fond et avec la plaque supérieure, respectivement ;
  • le fond comporte un bord qui s'étend verticalement vers le haut et qui entoure la plaque supérieure ;
  • la plaque supérieure est un volet qui est monté articulé autour d'un axe transversal au moyen d'une première charnière sur un côté du fond qui est dénué de bord vertical ;
  • la première charnière est formée par un film de plastique qui est réalisé venu de matière avec le fond et avec la plaque supérieure ;
  • la première charnière forme butée de positionnement du blister par rapport aux trous du fond ;
  • l'étui comporte un couvercle supérieur de protection des alvéoles qui est réalisé en matière plastique rigide et qui est monté pivotant par rapport au fond autour d'une seconde charnière entre une position fermée dans laquelle il enveloppe les alvéoles du blister par coopération de forme avec le fond, et une position ouverte dans laquelle les alvéoles sont accessibles à un utilisateur ;
  • la seconde charnière est un film de plastique qui est réalisé venu de matière avec le fond et le couvercle ;
  • le couvercle est maintenu en position fermée par des moyens par coopération de formes complémentaires entre le couvercle et la plaque supérieure et/ou le fond ;
  • l'emboîtement élastique est réalisé par déformation élastique de l'élément femelle.
According to other features of the invention:
  • the case comprises at least one lug forming a stop for horizontal positioning of the blister with respect to the ejection holes in the bottom of the case;
  • the lug constitutes a male element of the fastening means by elastic interlocking, the associated female element being carried by the upper plate;
  • the male element and the female element are made integrally with the bottom and the top plate, respectively;
  • the bottom has an edge that extends vertically upward and surrounds the top plate;
  • the upper plate is a flap which is mounted hinged about a transverse axis by means of a first hinge on one side of the bottom which is devoid of vertical edge;
  • the first hinge is formed by a plastic film which is made integral with the bottom and the top plate;
  • the first hinge forms the positioning stop of the blister with respect to the bottom holes;
  • the case comprises an upper cover for protection of the cells which is made of rigid plastics material and which is pivotally mounted relative to the bottom around a second hinge between a closed position in which it envelopes the cells of the blister by form cooperation with the bottom, and an open position in which the cells are accessible to a user;
  • the second hinge is a plastic film which is made integrally with the bottom and the lid;
  • the lid is held in the closed position by means of cooperation of complementary shapes between the lid and the upper plate and / or the bottom;
  • the elastic engagement is achieved by elastic deformation of the female element.

D'autres caractéristiques et avantages de l'invention apparaîtront au cours de la lecture de la description détaillée qui suit pour la compréhension de laquelle on se reportera aux dessins annexés parmi lesquels :

  • la figure 1 est une vue en perspective éclatée d'un étui de protection réalisé selon les enseignements de l'invention, l'étui étant ouvert et déplié, prêt à recevoir un blister de médicaments ;
  • la figure 2 représente l'étui de la figure 1 avec son couvercle en position ouverte qui montre le blister de médicament emprisonné dans l'étui ;
  • la figure 3 est une vue de dessus qui illustre le fond de l'étui sur lequel blister de médicament est positionné ;
  • la figure 4 est une vue en perspective et en section partielle selon le plan de coupe 4-4 de la figure 2 qui représente en détail les moyens de fixation par emboîtement élastique du volet intermédiaire sur le fond de l'étui, avant l'emboîtement ;
  • la figure 5 est une vue qui représente les moyens de fixation de la figure 4, après l'emboîtement ;
  • la figure 6 représente l'étui de la figure 1 avec son couvercle qui est en position fermée et qui comporte une notice d'information ;
  • la figure 7 est une vue à grande échelle et en section longitudinale selon le plan de coupe 7-7 de la figure 6.
Other features and advantages of the invention will appear during the reading of the detailed description which follows for the understanding of which reference will be made to the appended drawings in which:
  • Figure 1 is an exploded perspective view of a protective case made according to the teachings of the invention, the case being opened and unfolded, ready to receive a drug blister;
  • Figure 2 shows the case of Figure 1 with its cover in the open position showing the drug blister trapped in the case;
  • Figure 3 is a top view illustrating the bottom of the case on which drug blister is positioned;
  • FIG. 4 is a view in perspective and in partial section along the sectional plane 4-4 of FIG. 2, which shows in detail the fastening means by elastic interlocking of the intermediate flap on the bottom of the case, before the interlocking ;
  • Figure 5 is a view which shows the fixing means of Figure 4, after the interlocking;
  • FIG. 6 represents the case of FIG. 1 with its cover which is in the closed position and which comprises an information notice;
  • FIG. 7 is a view on a large scale and in longitudinal section along the sectional plane 7-7 of FIG. 6.

On utilisera dans la suite de la description et dans les revendications, à titre non limitatif, une orientation longitudinale, verticale et tranversale indiquée par le trièdre L, V, T de la figure 1.A longitudinal, vertical and transverse orientation indicated by the trihedron L, V, T of FIG. 1 will be used in the remainder of the description and in the claims, in a non-limiting manner.

On a représenté à la figure 1 un étui 10 de protection d'un blister 12 de médicaments. L'étui 10 est ici vide et il est dans un état déplié d'origine dans lequel il est prêt à recevoir le blister de médicaments 12.There is shown in Figure 1 a protective case 10 of a blister 12 of drugs. The case 10 is here empty and is in an unfolded state of origin in which it is ready to receive the drug blister 12.

De manière connue, le blister 12 comporte une plaque supérieure 14 horizontale semi-rigide qui comprend des alvéoles 16, en forme de cloques délimitant des logements ouverts vers le bas qui sont obturés par des opercules 17 représentés à la figure 7. Chacun des logements peut abriter un médicament 19 susceptible d'être expulsé par la face inférieure plate 18 du blister 12 par déformation de l'alvéole 16 et par déchirure de l'opercule 17 comme illustré par l'alvéole centrale 16 à la figure 7. Les médicaments 19 sont conditionnés par exemple sous forme de comprimés, de gélules, de suppositoires susceptibles d'être protégés par un blister.In known manner, the blister 12 comprises a semi-rigid horizontal top plate 14 which comprises cells 16, in the form of blisters defining open housing downwards which are closed by lids 17 shown in Figure 7. Each housing can to shelter a drug 19 that can be expelled by the flat lower face 18 of the blister 12 by deformation of the cell 16 and by tearing of the lid 17 as illustrated by the central cell 16 in FIG. 7. The drugs 19 are packaged for example in the form of tablets, capsules, suppositories likely to be protected by a blister.

L'étui 10 comporte notamment un fond central 20 qui est principalement formé par une plaque horizontale globalement rectangulaire dont les petits côtés avant 22 et arrière 24 sont orientés transversalement et dont les grands côtés latéraux 26 et 28 sont orientés longitudinalement selon la figure 1.The case 10 comprises in particular a central bottom 20 which is mainly formed by a horizontal plate generally rectangular whose small front sides 22 and rear 24 are oriented transversely and whose long lateral sides 26 and 28 are oriented longitudinally according to Figure 1.

Le fond 20 est notamment destiné à supporter la face inférieure plate 18 du blister 12 qui est posé selon la flèche F de la figure 1.The bottom 20 is in particular intended to support the flat lower face 18 of the blister 12 which is placed along the arrow F of FIG.

La plaque de fond 20 comporte un bord latéral 30 qui s'étend verticalement vers le haut depuis les deux grands côtés 26 et 28 ainsi que depuis le petit côté arrière 24.The bottom plate 20 has a side edge 30 which extends vertically upwardly from the two long sides 26 and 28 as well as from the rear small side 24.

Un volet 32 rectangulaire et plat, de dimensions sensiblement complémentaires de celles du fond 20, est monté articulé autour d'une charnière transversale avant 34, sur le petit côté avant 22 du fond 20, entre une position dépliée et une position rabattue.A rectangular and flat flap 32, of dimensions substantially complementary to those of the bottom 20, is mounted articulated around a transverse hinge front 34, on the small front side 22 of the bottom 20, between an unfolded position and a folded position.

En position dépliée, comme représentée à la figure 1, le volet 32 découvre totalement le fond 20 de l'étui 10.In the unfolded position, as represented in FIG. 1, the flap 32 completely discovers the bottom 20 of the case 10.

En position rabattue, comme représentée aux figures 2 et 7, le volet 32 recouvre globalement le fond 20 afin d'emprisonner le blister 12 entre la face inférieure 36 du volet 32 et la face supérieure 38 du fond 20. Le volet 32 est alors entouré par le bord 30 du fond 20.In the folded position, as shown in FIGS. 2 and 7, the flap 32 generally covers the bottom 20 in order to trap the blister 12 between the lower face 36 of the flap 32 and the upper face 38 of the bottom 20. The flap 32 is then surrounded by the edge 30 of the bottom 20.

Le volet 32 et le fond 20 comportent respectivement des trous 40 et 42 qui sont réalisés en concordance avec les emplacements des alvéoles 16 du blister 12 lorsque le volet 32 est en position rabattue. Les alvéoles 16 et les trous 40 et 42 sont ici réalisés sous la forme de quatre rangées longitudinales de neuf unités.The flap 32 and the bottom 20 respectively comprise holes 40 and 42 which are made in concordance with the locations of the cells 16 of the blister 12 when the flap 32 is in the folded position. The cells 16 and the holes 40 and 42 are here made in the form of four longitudinal rows of nine units.

Comme représenté à la figure 2, les trous 40 du volet 32 donnent accès aux alvéoles 16 à l'utilisateur qui peut ainsi sélectionner un médicament 19 et l'éjecter en appuyant verticalement sur l'alvéole 16 choisie, le médicament 19 étant alors éjecté à travers l'opercule 17 et par le trou associé 42 du fond 20 comme illustré par la flèche F' de la figure 7.As shown in FIG. 2, the holes 40 of the flap 32 give access to the cells 16 to the user who can thus select a drug 19 and eject it by pressing vertically on the cell 16 chosen, the drug 19 being then ejected to through the cover 17 and the associated hole 42 of the bottom 20 as illustrated by the arrow F 'of FIG. 7.

L'étui 10 comporte des moyens indémontables ou inviolables de fixation du volet 32 en position rabattue sur le fond 20. Le volet 32 est plus précisément fixé par emboîtement élastique vertical d'une série de paires d'éléments comportant chacun un élément mâle 44 et un élément femelle 46. Les moyens de fixations sont représentés plus en détail aux figures 4 et 5.The case 10 comprises non-removable or tamper-proof means for fastening the flap 32 in the folded position on the bottom 20. The flap 32 is more precisely fixed by vertical elastic engagement of a series of pairs of elements each comprising a male element 44 and a female element 46. The fastening means are shown in more detail in FIGS. 4 and 5.

L'élément mâle 44 est constitué d'un ergot 48 qui s'étend verticalement vers le haut depuis la face supérieure 38 du fond 20. L'extrémité libre de l'ergot 48 comporte une tête 50 en forme de demi-sphère dont le méplat horizontal est orienté vers le bas.The male element 44 consists of a lug 48 which extends vertically upwards from the upper face 38 of the bottom 20. The free end of the lug 48 has a head 50 in the form of a half-sphere whose horizontal flat is oriented downwards.

L'ergot 48 est destiné à coopérer avec l'élément femelle 46 associé qui est porté par le volet 32. Selon ce mode de réalisation, l'élément femelle 46 est un puits 54 avec un fond percé qui s'étend verticalement depuis la surface supérieure 56 du volet 32. Le puits 54 comporte une ouverture inférieure 52 destinée à recevoir la tête hémisphérique 50 de l'ergot 48.The lug 48 is intended to cooperate with the associated female element 46 which is carried by the flap 32. According to this embodiment, the female element 46 is a well 54 with a pierced bottom which extends vertically from the surface upper portion 56 of the flap 32. The well 54 has a lower opening 52 intended to receive the hemispherical head 50 of the lug 48.

Le puits 54 comporte aussi des fentes verticales qui divisent le puits 54 en deux moitiés symétriques afin de faciliter sa déformation élastique et par conséquent l'emboîtement de l'élément mâle 44.The well 54 also has vertical slots which divide the well 54 into two symmetrical halves in order to facilitate its elastic deformation and consequently the engagement of the male element 44.

Ainsi, lorsque l'ergot 48 est emboîté dans l'élément femelle 46, comme représenté à la figure 5, l'extrémité supérieure du puits 54 est en butée avec le méplat inférieur de l'ergot 48 afin d'empêcher tout mouvement vertical du volet 32 par rapport au fond 20. Le volet 32 est ainsi solidarisé au fond 20, et le blister 12 est emprisonné dans l'étui 10.Thus, when the lug 48 is fitted into the female element 46, as shown in FIG. 5, the upper end of the well 54 abuts with the lower flat surface of the lug 48 in order to prevent any vertical movement of the lug 48. flap 32 with respect to the bottom 20. The flap 32 is thus secured to the bottom 20, and the blister 12 is trapped in the case 10.

De plus, le puits 54 à une forme tronconique dont la base inférieure est située à l'ouverture 52 et qui est destinée à augmenter la résistance au déboîtement par effet de pince.In addition, the well 54 has a frustoconical shape whose lower base is located at the opening 52 and which is intended to increase the resistance to disengagement by clamping effect.

Comme on peut le voir à la figure 1, les orifices 52 d'emboîtement du volet 32 sont encerclés par une jupe 58 de protection des paires d'éléments de fixation 44, 46 qui s'étend verticalement depuis la surface supérieure 56 du volet 32 et qui empêche toute tentative de démontage par écartement des deux moitiés de chaque puits 54.As can be seen in FIG. 1, the engagement apertures 52 of the shutter 32 are encircled by a skirt 58 for protecting the pairs of fixing elements 44, 46 which extends vertically from the upper surface 56 of the shutter 32 and that prevents any attempt to disassemble by spacing the two halves of each well 54.

Comme représenté à la figure 3, les paires d'éléments 44, 46 de fixation par emboîtement élastique sont ici au nombre de six. Les ergots 48 portés par le fond 20 sont répartis sur le pourtour du fond 20 à raison de deux ergots latéraux 48L sur chaque grand côté latéral 26 et 28 du fond 20 et de deux ergots frontaux 48F sur le petit côté arrière 24. Les ergots 48 déterminent précisément la position horizontale du blister 12 par rapport aux trous d'éjection 42 lors de la mise en place de ce dernier dans le fond 20 et avant de rabattre le volet 32. Le petit côté avant 22 du blister 12 est adjacent à la charnière avant 34.As shown in Figure 3, the pairs of elements 44, 46 for fixing elastic interlocking are here six in number. The lugs 48 carried by the bottom 20 are distributed on the periphery of the bottom 20 at the rate of two lateral lugs 48L on each large lateral side 26 and 28 of the bottom 20 and two front lugs 48F on the small rear side 24. The lugs 48 determine precisely the horizontal position of the blister 12 with respect to the ejection holes 42 during the introduction of the latter in the bottom 20 and before folding the flap 32. The small front side 22 of the blister 12 is adjacent to the hinge before 34.

Les ergots 48 ainsi que la charnière avant 34 forment ainsi avantageusement des butées de positionnement du blister 12 par rapport au fond 20.The lugs 48 and the front hinge 34 thus advantageously form positioning stops for the blister 12 relative to the bottom 20.

L'étui 10 comporte aussi un couvercle 60 qui est notamment visible aux figures 2 et 6. Le couvercle 60 est une plaque de dimensions globalement similaires à celles du fond 20. Le couvercle 60 est monté articulé sur la tranche supérieure du bord 30 du petit côté arrière 24, autour d'une charnière transversale arrière 62, entre une position ouverte et une position fermée.The case 10 also comprises a cover 60 which is particularly visible in FIGS. 2 and 6. The cover 60 is a plate of dimensions roughly similar to those of the bottom 20. The cover 60 is hingedly mounted on the upper edge of the edge 30 of the small rear side 24, around a rear transverse hinge 62, between an open position and a closed position.

En position ouverte, comme illustrée à la figure 2, le couvercle 60 découvre la partie supérieure du blister 12 de façon à permettre l'accès aux médicaments 19 à un utilisateur. Le couvercle peut être ouvert à 180° en libérant totalement l'accès au blister.In the open position, as illustrated in Figure 2, the lid 60 discovers the upper portion of the blister 12 so as to allow access to the drugs 19 to a user. The lid can be opened at 180 ° while completely freeing access to the blister.

En position fermée, comme illustré à la figure 6, le couvercle 60 est globalement horizontal et son revers inférieur 64 est appuyé sur la tranche supérieure du bord 30 du fond 20. Le couvercle 60 comporte à son extrémité libre, c'est-à-dire le côté opposé à la charnière arrière 62, une aile 66 qui s'étend perpendiculairement à partir de son revers 64 de façon à fermer le petit côté avant 22 de l'étui 10 qui est dépourvu de bord vertical 30.In the closed position, as shown in FIG. 6, the cover 60 is generally horizontal and its lower cuff 64 is pressed on the upper edge of the edge 30 of the bottom 20. The cover 60 has at its free end, that is to say say the opposite side to the rear hinge 62, a flange 66 which extends perpendicularly from its cuff 64 so as to close the small front side 22 of the case 10 which has no vertical edge 30.

Ainsi, le couvercle 60 enferme et protège la face supérieure 14 du blister 12, et notamment les alvéoles 16. En position fermée, seul l'avers 68 du couvercle 60 est visible.Thus, the cover 60 encloses and protects the upper face 14 of the blister 12, and in particular the cells 16. In the closed position, only the obverse 68 of the cover 60 is visible.

L'avers 68 du couvercle 60 peut notamment servir de support à une notice d'informations 70 sur les médicaments 19 contenus dans l'étui 10. La notice 70 est par exemple collée sur l'avers 68 ou sur l'envers 64. La notice peut aussi être imprimée ou inscrite sur le couvercle en creux ou en relief.The obverse 68 of the cover 60 may in particular serve as a support for an information notice 70 on the drugs 19 contained in the case 10. The notice 70 is for example glued on the obverse 68 or on the reverse side 64. The The record can also be printed or inscribed on the cover in recess or in relief.

Le volet 32 comporte deux pattes 72 qui le prolonge en saillie au-delà de la charnière avant 34. En position rabattue du volet 32, ces deux pattes 72 s'étendent horizontalement depuis le petit côté avant 22 de l'étui 10.The flap 32 has two tabs 72 which protrude beyond the front hinge 34. In the folded position of the flap 32, these two tabs 72 extend horizontally from the small front side 22 of the case 10.

Les pattes 72 sont destinées à accrocher le couvercle 60 en position fermée par emboîtement élastique avec des rainures (non représentées) portées par l'aile 66 du couvercle 60.The tabs 72 are intended to hook the lid 60 in the closed position by elastic interlocking with grooves (not shown) carried by the flange 66 of the lid 60.

Le milieu de l'aile 66 du couvercle 60 dessine un bossage 74 formant une prise pour permettre à l'utilisateur de désengager le couvercle 60 de l'emprise des pattes 72 afin d'ouvrir l'étui 10 en le soulevant.The middle of the flange 66 of the cover 60 draws a boss 74 forming a grip to allow the user to disengage the cover 60 from the grip of the tabs 72 to open the case 10 by lifting.

L'étui 10 est ici réalisé entièrement en matière plastique rigide. L'étui 10 est ainsi résistant aux chocs, et ses propriétés mécaniques ne sont pas altérées en cas d'exposition à une atmosphère humide.The case 10 is here made entirely of rigid plastic material. The case 10 is thus resistant to shocks, and its mechanical properties are not altered when exposed to a humid atmosphere.

Selon ce mode de réalisation, l'étui 10 est réalisé venu de matière par moulage en une seule pièce. Les charnières avant 34 et arrière 62 sont alors chacune constituée d'un film de plastique venu de matière avec le fond 20. L'étui 10 est avantageusement constitué d'un matériau du type polypropylène de façon que les fermetures et ouvertures répétées du couvercle 60 ne provoquent pas de rupture par fatigue de la charnière arrière 62 durant l'utilisation de l'étui 10.According to this embodiment, the case 10 is made integrally by molding in one piece. The front hinges 34 and rear 62 are then each made of a plastic film integrally formed with the bottom 20. The case 10 is advantageously made of a polypropylene-type material so that the closures and repeated openings of the lid 60 do not cause fatigue failure of the rear hinge 62 during use of the case 10.

Les ergots 48 sont aussi réalisés venus de matière avec le fond 20, et les éléments femelles sont réalisés venus de matière avec le volet 32. La fabrication de cet étui 10 ne nécessite ainsi aucune opération d'assemblage puisqu'il est constitué d'une seule pièce.The lugs 48 are also made integral with the bottom 20, and the female elements are made integrally with the flap 32. The manufacture of this case 10 does not require any assembly operation since it consists of a single piece.

Lors de l'opération de conditionnement du blister 12 dans l'étui 10, un opérateur pose le blister 12, alvéoles 16 vers le haut, sur le fond 20 entre les ergots 48 comme illustré par la flèche F de la figure 1, l'étui 10 étant déplié, avec ses trois parties 20, 32 et 60 horizontales telles qu'à la sortie du moule.During the operation of packaging the blister 12 in the case 10, an operator places the blister 12, cells 16 upwards, on the bottom 20 between the lugs 48 as illustrated by the arrow F of FIG. case 10 being unfolded, with its three parts 20, 32 and 60 horizontal such as at the outlet of the mold.

Ensuite, le volet 32 est rabattu par-dessus le blister 12 contre le fond 20. Le blister 12 est alors automatiquement positionné horizontalement car la pliure formée au niveau de la charnière avant 34 par le volet 32 et le fond 20 pousse le blister 12 qui est guidé latéralement en position par les ergots latéraux 48L, et arrêté en butée contre les ergots frontaux 48F.Then, the flap 32 is folded over the blister 12 against the bottom 20. The blister 12 is then automatically positioned horizontally because the fold formed at the front hinge 34 by the flap 32 and the bottom 20 pushes the blister 12 which is laterally guided in position by the lateral lugs 48L, and stopped in abutment against the front lugs 48F.

Les puits 54 du volet 32 sont alors amenés verticalement en contact avec les ergots 48 qui pénètrent par l'ouverture inférieure 52. La tête bombée 50 de l'ergot 48 écarte élastiquement les deux moitiés du puits 54. Puis, le puits 54 est rappelé élastiquement dans sa forme d'origine contre l'ergot 48, sous la tête 50. Les paires d'éléments de fixation 44 et 46 sont alors en position emboîtée et le volet 32 emprisonne ainsi le blister 12 contre le fond 20 de façon indémontable.The wells 54 of the flap 32 are then brought vertically in contact with the lugs 48 which penetrate through the lower opening 52. The rounded head 50 of the lug 48 elastically separates the two halves of the well 54. Then, the well 54 is recalled elastically in its original form against the lug 48, under the head 50. The pairs of fasteners 44 and 46 are then in the nested position and the flap 32 thus traps the blister 12 against the bottom 20 in a way that can not be dismantled.

Grâce à cet étui 10, il n'est pas nécessaire de positionner exactement le blister 12 dans l'étui 10, puisque le positionnement exact est obtenu lorsque le volet 32 est rabattu puis fixé. Cette méthode de fixation est avantageusement rapide et ne fait appel à aucun moyen extérieur.With this case 10, it is not necessary to exactly position the blister 12 in the case 10, since the exact positioning is obtained when the flap 32 is folded and fixed. This method of attachment is advantageously fast and does not use any external means.

Lors de l'utilisation de l'étui 10, l'utilisateur saisi l'étui 10 fermé en supportant la face inférieure du fond 20 dans la paume de sa main et en serrant les deux grands côtés latéraux 26 et 28 entre ses doigts. Puis il ouvre de l'autre main le couvercle 60 de l'étui 10 en soulevant le bossage 74. Enfin, il presse du doigt l'alvéole 16 contenant le médicament 19 désiré afin de l'éjecter par le trou 42 du fond 20, dans la paume de la main qui soutient l'étui 10.When using the case 10, the user grasps the case 10 closed by supporting the underside of the bottom 20 in the palm of his hand and squeezing the two large lateral sides 26 and 28 between his fingers. Then he opens with the other hand the cover 60 of the case 10 by lifting the boss 74. Finally, he presses the finger the cell 16 containing the desired drug 19 to eject it through the hole 42 of the bottom 20, in the palm of the hand that supports the case 10.

Un tel étui 10 rend difficile toute tentative de viol pour en retirer le blister 12.Such a case 10 makes it difficult to attempt rape to remove the blister 12.

En effet, le volet 32 étant entouré de très près par le bord 30 du fond 20, il est difficile de prendre appui pour insérer un levier dans l'interstice entre le volet 32 et le fond 20 en vue de soulever le volet 32.Indeed, the flap 32 being surrounded very closely by the edge 30 of the bottom 20, it is difficult to support to insert a lever in the gap between the flap 32 and the bottom 20 to lift the flap 32.

Il est aussi difficile de tenter d'écarter les lamelles 54 qui bordent l'orifice d'emboîtement 52 du volet 32 afin de libérer la tête 50 de l'ergot 48 correspondant car le pourtour de l'orifice 52 est protégé par la jupe 58. De plus, il faudrait réaliser cette opération simultanément sur les six moyens de fixation simultanément à cause de la rigidité du volet 32.It is also difficult to attempt to spread the slats 54 which border the nesting orifice 52 of the flap 32 in order to release the head 50 of the corresponding lug 48 because the periphery of the orifice 52 is protected by the skirt 58 In addition, this operation should be performed simultaneously on the six fastening means simultaneously because of the rigidity of the flap 32.

Ainsi, la seule solution pour atteindre le blister 12 est de découper les têtes 50 de chaque ergot 48, ce qui laisse des traces ineffaçables. C'est-à-dire qu'en cas de viol, l'étui 10 porte des traces impossibles à camoufler.Thus, the only solution to reach the blister 12 is to cut the heads 50 of each lug 48, leaving indelible traces. That is to say that in case of rape, the case 10 carries traces impossible to camouflage.

Dans une variante non représentée de l'invention, le volet 32 et le fond 20 sont deux pièces distinctes.In a variant not shown of the invention, the flap 32 and the bottom 20 are two separate parts.

Claims (12)

  1. A protective case (10) for a blister pack (12) containing medicines (19) intended for clinical trials, of the type comprising a semi-rigid horizontal upper panel (14) comprising blister-shaped cells (16) delimiting housings open at the bottom and which are obturated by covers (17) and each of which contains a medicine (19) able to be expelled by the flat lower face (18) of the blister pack (12) by tearing the cover (17) of the blister (12), and of the type wherein the case (10) comprises:
    - a perforated horizontal bottom (20) upon which the lower face (18) of the blister pack (12) lays; and
    - a perforated upper panel (32) which covers the upper face (14) of the blister pack (12);
    and of the type in which the blister pack (12) is trapped between the bottom (20) and the upper panel (32) each of which comprise holes (40, 42) coinciding with the location of the cells (16), the case comprising means (44, 46) of fixing the upper panel (32) with respect to the bottom (20), the bottom (20) and the upper panel (32) of the case (10) being made of rigid plastic,
    characterized in that the fixing means (44, 46) are elastic interlocking means that cannot be dismantled.
  2. The case (10) as claimed in the preceding claim, characterized in that it comprises at least one pin (48) forming a stop for the horizontal positioning of the blister pack (12) with respect to the ejection holes (42) in the bottom (20) of the case (10).
  3. The case (10) as claimed in the preceding claim, characterized in that the pin (48) constitutes a male element (44) of the elastic interlocking fixing means, the associated female element (46) being carried by the upper panel (32).
  4. The case (10) as claimed in one of the preceding claims, characterized in that the male element (44) and the female element (46) are formed in one piece with the bottom (20) and with the top panel (32) respectively.
  5. The case (10) as claimed in one of the preceding claims, characterized in that the bottom (20) comprises a rim (30) that extends vertically upwards and which surrounds the upper panel (32).
  6. The case (10) as claimed in one of the preceding claims, characterized in that the upper panel is a flap (32) that is mounted such that it articulates about a transverse axis by means of a first hinge (34) on one side (22) of the bottom (20) which has no vertical rim (30).
  7. The case (10) as claimed in the preceding claim, characterized in that the first hinge (34) is formed by a plastic film which is formed in one piece with the bottom (20) and with the upper panel (32).
  8. The case (10) as claimed in one of claims 6 or 7, characterized in that the first hinge (34) forms a stop for positioning the blister pack (12) with respect to the holes (42) in the bottom (20).
  9. The case (10) as claimed in one of claims 5 to 8, characterized in that it comprises an upper lid (60) for protecting the cells (16) which is made of rigid plastic and which is mounted such that it pivots with respect to the bottom about a second hinge (62) between a closed position in which it envelopes the cells (16) of the blister pack (12) by cooperation of its shape with that of the bottom (20), and an open position in which the cells (16) are accessible to a user.
  10. The case (10) as claimed in the preceding claim, characterized in that the second hinge (62) is a plastic film which is formed in one piece with the bottom (20) and the lid (60).
  11. The case (10) as claimed in one of claims 9 or 10, characterized in that the lid (60) is held in the closed position by means working by cooperation of complementary shapes (72) between the lid (60) and the upper panel (32) and/or the bottom (20).
  12. The case (10) as claimed in one of the preceding claims, characterized in that the elastic interlocking is produced by elastic deformation of the female element (46).
EP03773732A 2002-10-14 2003-10-07 Rigid plastic protective case for a blister pack Expired - Lifetime EP1554191B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0212719 2002-10-14
FR0212719A FR2845668B1 (en) 2002-10-14 2002-10-14 CASE FOR PROTECTING A BLISTER MADE OF RIGID PLASTIC MATERIAL
PCT/EP2003/050699 WO2004035414A1 (en) 2002-10-14 2003-10-07 Rigid plastic protective case for a blister pack

Publications (2)

Publication Number Publication Date
EP1554191A1 EP1554191A1 (en) 2005-07-20
EP1554191B1 true EP1554191B1 (en) 2006-06-07

Family

ID=32039684

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03773732A Expired - Lifetime EP1554191B1 (en) 2002-10-14 2003-10-07 Rigid plastic protective case for a blister pack

Country Status (10)

Country Link
US (1) US7419056B2 (en)
EP (1) EP1554191B1 (en)
JP (1) JP4727991B2 (en)
AR (1) AR041576A1 (en)
AT (1) ATE328810T1 (en)
AU (1) AU2003282116A1 (en)
DE (1) DE60305957T2 (en)
FR (1) FR2845668B1 (en)
TW (1) TW200406189A (en)
WO (1) WO2004035414A1 (en)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101103350A (en) 2004-04-24 2008-01-09 鹰锐系统股份有限公司 Integrated, non-sequential, remote medication management and compliance system
US7828147B2 (en) 2004-04-24 2010-11-09 Inrange Systems, Inc. Multi-layer medication carrier
GB2430928A (en) * 2005-10-07 2007-04-11 Boots Healthcare Int Ltd Casing for blister pack
US7331460B2 (en) * 2006-01-04 2008-02-19 R.P. Scherer Technologies, Inc. Shielded medicament package
US20080164259A1 (en) * 2007-01-04 2008-07-10 Coe Matthew T Container useful for holding multiple articles of manufacture
US7607538B2 (en) * 2007-08-27 2009-10-27 Schering-Plough Healthcare Products, Inc. Container for transporting a blister package
US7959481B1 (en) * 2008-05-09 2011-06-14 Thomas Wayne Towed-sports handle safety device
US8579106B2 (en) * 2008-05-21 2013-11-12 Bilcare Limited Packaged-product system with multi-operational access control
JP5583671B2 (en) * 2008-09-12 2014-09-03 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Packaging unit
US8689978B2 (en) 2011-11-03 2014-04-08 Berlin Packaging, Llc Hinged container holder for medication cards
US8708149B2 (en) 2011-11-03 2014-04-29 Berlin Packaging, Llc Flip container for blister card medication holders
US8899419B2 (en) 2012-03-28 2014-12-02 Aventisub Ii Inc. Package with break-away clamshell
USD694644S1 (en) 2012-03-28 2013-12-03 Aventisub Ii Inc. Clamshell package having blisters
US8919559B2 (en) 2012-03-28 2014-12-30 Aventisub Ii Inc. Package with break-away clamshell
USD697813S1 (en) 2012-03-28 2014-01-21 Aventisub Ii Inc. Clamshell having blisters received therein
USD687313S1 (en) 2012-03-28 2013-08-06 Aventisub Ii Inc. A-shaped blister card
USD695625S1 (en) 2012-03-28 2013-12-17 Aventisub Ii Inc. Package for product
USD693695S1 (en) 2012-03-28 2013-11-19 Aventisub Ii Inc. Package for product
US9108784B2 (en) * 2012-06-29 2015-08-18 R.J. Reynolds Tobacco Company Dispensing container, packaged product assembly, and related method
USD731783S1 (en) * 2014-04-16 2015-06-16 Abbvie Inc. Template for a prescription medicine container
US9406245B2 (en) 2014-09-03 2016-08-02 Michael Barbera Patient medicine identity display
ES2626779T3 (en) * 2014-09-08 2017-07-26 Edwin Kohl Installation and procedure for repackaging different medicines from their respective original blisters to filling blisters
US20160338517A1 (en) * 2014-10-28 2016-11-24 Chad Raynell Snowden Tray insert with retained food service items
US9414993B2 (en) * 2014-12-09 2016-08-16 Michael Flynn Sealable pill organizer and dispenser
JP6476316B2 (en) 2015-06-30 2019-02-27 イー・エム・デイー・ミリポア・コーポレイシヨン Sealing case for filter cassette
CH718159A1 (en) * 2020-12-15 2022-06-15 Doryhealth Ag Device for receiving a press-through packaging.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3587517A (en) * 1969-07-29 1971-06-28 Upjohn Co Dispenser
US3921804A (en) * 1974-05-09 1975-11-25 William W Tester Medication dispensing package
US4384649A (en) * 1980-12-11 1983-05-24 E. R. Squibb & Sons, Inc. Dispensing package
DE8503564U1 (en) * 1985-02-09 1985-05-15 Simon, Udo, 8500 Nürnberg Device for storing and timed taking of medicaments
GB8518828D0 (en) * 1985-07-25 1985-08-29 American Home Prod Tablet package
JPS6374323A (en) * 1986-09-18 1988-04-04 Yokogawa Electric Corp Current source circuit
US4998623A (en) * 1990-04-27 1991-03-12 Omni Medical Systems Inc. Medication dispensing package
US5109984A (en) * 1990-06-22 1992-05-05 Romick Jerome M Unit-dose medication handling and dispensing system
JPH0471662A (en) * 1990-07-09 1992-03-06 Dainippon Printing Co Ltd Production of sheet for electronic parts transferring body
US5323907A (en) * 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
US5489025A (en) * 1994-03-01 1996-02-06 Romick; Jerome M. Unit-dose medication dispenser and multiple-dispenser frame therefor
GB9713876D0 (en) * 1997-06-30 1997-09-03 Glaxo Group Ltd Device for holding blister pack
US5988429A (en) * 1997-10-14 1999-11-23 Pharmadesign, Inc. Blister pack pill dispenser
US6021901A (en) * 1998-09-21 2000-02-08 Owens-Illinois Closure Inc. Child-resistant container
US6082544A (en) * 1999-02-01 2000-07-04 Artromick International, Inc. Medicine unit dose dispensing system and method
DE19957809B4 (en) * 1999-12-01 2005-11-03 EURIM-PHARM Vertriebs-GmbH & Co. KG Use of a blister pack

Also Published As

Publication number Publication date
FR2845668B1 (en) 2005-08-05
AR041576A1 (en) 2005-05-18
ATE328810T1 (en) 2006-06-15
TW200406189A (en) 2004-05-01
EP1554191A1 (en) 2005-07-20
JP2006502775A (en) 2006-01-26
US20060118452A1 (en) 2006-06-08
FR2845668A1 (en) 2004-04-16
WO2004035414A1 (en) 2004-04-29
DE60305957T2 (en) 2007-06-14
AU2003282116A1 (en) 2004-05-04
US7419056B2 (en) 2008-09-02
DE60305957D1 (en) 2006-07-20
JP4727991B2 (en) 2011-07-20

Similar Documents

Publication Publication Date Title
EP1554191B1 (en) Rigid plastic protective case for a blister pack
EP1899242B1 (en) Package for goods
FR2544695A1 (en) CHILD RESISTANT SECURITY CONTAINER
EP3016880B1 (en) Packaging enclosing lozenge products and blank for obtaining said packaging
CA1294583C (en) Packinging closed by slide fastener and having at least one retractable panel
FR2764274A1 (en) Packaging incorporating plastic cavitied packaging plates for medical tablets and gels
WO2006024774A1 (en) Package for confectionery product
FR2791321A1 (en) PACKAGING IN SEMI-RIGID MATERIAL, COMPRISING A BODY AND A PIVOTING MOUNTED PART FORMING A CLOSABLE COVER
EP0802876B1 (en) Tamper-resistant packaging box
FR3105189A1 (en) Bulk product gravity flow dispenser
FR2787420A1 (en) SHIPPING PACKAGE WITH ADDITIONAL SECURITY
FR2638430A3 (en) Packaging for prepacked pharmaceutical products of the tablet, capsule, lozenge or similar type
WO2005044675A1 (en) Case comprising a rigid face and a flexible face, which can be closed and kept closed
EP1398277A1 (en) Secure blister pack for pharmaceutical use, card and corresponding method of production
EP0656854B1 (en) Packaging for small objects
FR2700314A1 (en) Tray for containing various products, especially food and horticultural products
FR3124430A1 (en) Device for packaging a dose of a solid or pasty product placed in a reservoir
EP2685956B1 (en) Packaging for unit pharmaceutical products
WO2023036694A1 (en) Parcel comprising means for retaining at least one object
FR2760428A1 (en) SAFETY PACKAGING BOX
FR2797252A1 (en) PACKAGING OF SEMI-RIGID MATERIAL SUCH AS CARDBOARD FOR GOODS TO BE PLACED ON LINEAR LARGE SURFACES
BE851472A (en) CONTAINER SAFETY CLOSURE DEVICE
FR2622173A2 (en) Package with slides provided with a retractable panel and its manufacturing method.
FR2875480A1 (en) Package for containing e.g. bottle, has support pad enclosing and maintaining container in display position, and open-end box comprising opening which is enlarged by spacing lateral walls of box
FR2697806A1 (en) Impregnable sale box - has hinged cover hinged with locking tongue fitting in bottom and guarantee locking tongue fitting in cover

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20050322

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20060607

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060607

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060607

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060607

Ref country code: IE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060607

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060607

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060607

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060607

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060607

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

Free format text: NOT ENGLISH

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

Free format text: LANGUAGE OF EP DOCUMENT: FRENCH

REF Corresponds to:

Ref document number: 60305957

Country of ref document: DE

Date of ref document: 20060720

Kind code of ref document: P

GBT Gb: translation of ep patent filed (gb section 77(6)(a)/1977)

Effective date: 20060810

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060907

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060907

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060918

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20061031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061107

LTIE Lt: invalidation of european patent or patent extension

Effective date: 20060607

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
REG Reference to a national code

Ref country code: IE

Ref legal event code: FD4D

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20070308

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060908

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060607

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060907

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20061007

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061208

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060607

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060607

REG Reference to a national code

Ref country code: DE

Ref legal event code: R082

Ref document number: 60305957

Country of ref document: DE

Representative=s name: DREISS PATENTANWAELTE PARTNERSCHAFT, DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R081

Ref document number: 60305957

Country of ref document: DE

Owner name: SANOFI, FR

Free format text: FORMER OWNER: SANOFI-AVENTIS, PARIS, FR

Effective date: 20130205

Ref country code: DE

Ref legal event code: R082

Ref document number: 60305957

Country of ref document: DE

Representative=s name: DREISS PATENTANWAELTE PARTNERSCHAFT, DE

Effective date: 20130205

Ref country code: DE

Ref legal event code: R081

Ref document number: 60305957

Country of ref document: DE

Owner name: SANOFI-AVENTIS, FR

Free format text: FORMER OWNER: SANOFI-AVENTIS, PARIS, FR

Effective date: 20130205

Ref country code: DE

Ref legal event code: R082

Ref document number: 60305957

Country of ref document: DE

Representative=s name: DREISS PATENTANWAELTE PARTG MBB, DE

Effective date: 20130205

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20131014

Year of fee payment: 11

Ref country code: CH

Payment date: 20131014

Year of fee payment: 11

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20140930

Year of fee payment: 12

Ref country code: GB

Payment date: 20141001

Year of fee payment: 12

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20141031

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 13

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60305957

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20151007

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160503

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20151007

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20160919

Year of fee payment: 14

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20180629

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171031